Latest Breaking News On - Company oligophore - Page 1 : comparemela.com

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

01.05.2024 - Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) - Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira . Seite 1

United statesCovadonga paUnited states patent officeCompany nasdaqDevelopment officerCompany oligophoreAltamira therapeutics ltdAltamira therapeuticsAltamira therapeutic chief development

Altamira Therapeutics Files Second Provisional Patent

HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) Altamira’s polyKRASmut siRNA shown to knock down at least 65-91% of KRAS mutations in.

United statesCovadonga paAltamira therapeutics ltdAmerican cancer societySecurities exchangeSecurities exchange commissionCompany oligophoreUnited states patentTrade officeAltamira therapeutic chief operatingInvestigational new drugSecurities actSecurities exchange actAnnual reportSig transduct target therNasdaq cyto

Altamira Therapeutics (CYTO) Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Altamira Therapeutics (CYTO) Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCovadonga paCompany oligophoreAmerican cancer societyAltamira therapeutics ltdAltamira therapeuticsUnited states patentTrade officeAltamira therapeutic chief operatingInvestigational new drug

Altamira Therapeutics (CYTO) Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Altamira Therapeutics (CYTO) Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCovadonga paSecurities exchange commissionCompany oligophoreAltamira therapeutics ltdSecurities exchangeAmerican cancer societyUnited states patentTrade officeAltamira therapeutic chief operatingInvestigational new drugSecurities actSecurities exchange actAltamira therapeuticAltamira therapeutic annual reportAltamira therapeutics

Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023

Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSamuela wicklineCovadonga paSecurities exchange commissionCompany oligophoreCompany oligophore semaphoreAltamira therapeutics ltdSecurities exchangeAltamira therapeuticsLondon februaryBased therapeutics summitBoston marchChief operating officerChief scientific adviser